<?xml version='1.0' encoding='iso-8859-1'?>
<newsitem date="1997-06-27" id="root" itemid="691468" xml:lang="en">
<title>USA: IPO FILING - Leukosite files for 2.1 mln shrs.</title>
<headline>IPO FILING - Leukosite files for 2.1 mln shrs.</headline>
<dateline>WASHINGTON 1997-06-27</dateline>
<text>
<p>Leukosite Inc filed Friday with the U.S. Securities and Exchange Commission to register an initial public offering of up to 2.1 million common shares it expects to sell between $8 and $10 each.</p>
<p>Underwriters for the offering, Hambrecht &amp; Quist and UBS Securities, have an over-allotment option of up to 375,000 shares.</p>
<p>The Cambridge, Mass., biopharmaceutical company said proceeds from the sale will be used to fund research and development and for other general corporate needs.</p>
<p>After the offering, the company will have 8,683,176 shares outstanding, according to the SEC filing.</p>
<p>For the three months ended March 31, the company reported a net loss of $2.179 million. That compares to a net loss of $2.227 million in the year-earlier period.</p>
</text>
<copyright>(c) Reuters Limited 1997</copyright>
<metadata>
<dc element="dc.date.created" value="1997-06-27" />
<dc element="dc.publisher" value="Reuters Holdings Plc" />
<dc element="dc.date.published" value="1997-06-27" />
<dc element="dc.source" value="Reuters" />
<dc element="dc.creator.location" value="WASHINGTON" />
<dc element="dc.creator.location.country.name" value="USA" />
<dc element="dc.source" value="Reuters" />
</metadata>
</newsitem>